NMR icon

Nomura Holdings

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 22.2%
Negative

Positive
Zacks Investment Research
1 day ago
NMR or HOOD: Which Is the Better Value Stock Right Now?
Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Robinhood Markets, Inc. (HOOD). But which of these two companies is the best option for those looking for undervalued stocks?
NMR or HOOD: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
1 day ago
Is Nomura (NMR) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Nomura (NMR) Stock Undervalued Right Now?
Positive
Reuters
4 days ago
Nomura-backed Laser Digital secures conditional approval for US banking license
Nomura's digital asset subsidiary Laser Digital has secured conditional approval for a national trust bank charter, becoming the latest firm to ​benefit from the Trump administration's crypto-friendly stance.
Nomura-backed Laser Digital secures conditional approval for US banking license
Positive
Reuters
4 days ago
Nomura seeks US fund management acquisitions as part of global expansion
Japan's Nomura Holdings is looking for acquisition targets for its investment management business in the U.S. to build on last year's $1.8 billion buyout of ​Macquarie's U.S. and European public asset management businesses, its chief executive said ‌on Friday.
Nomura seeks US fund management acquisitions as part of global expansion
Positive
Zacks Investment Research
19 days ago
NMR or HOOD: Which Is the Better Value Stock Right Now?
Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Robinhood Markets, Inc. (HOOD). But which of these two companies is the best option for those looking for undervalued stocks?
NMR or HOOD: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
19 days ago
Should Value Investors Buy Nomura (NMR) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Nomura (NMR) Stock?
Neutral
Business Wire
1 month ago
Nomura Asset Management Appoints Chief Investment Strategist
PHILADELPHIA--(BUSINESS WIRE)--Nomura Asset Management today announced the appointment of Andrew “Andy” Goldberg as Chief Investment Strategist of Nomura Asset Management International1, a newly created role designed to elevate the firm's global thought leadership position and accelerate growth across our institutional and wealth channels. Andy will be responsible for developing and commercializing investment insights across the platform, positioning the firm as a leading voice on markets and i.
Nomura Asset Management Appoints Chief Investment Strategist
Positive
Zacks Investment Research
1 month ago
NMR vs. HOOD: Which Stock Is the Better Value Option?
Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Robinhood Markets, Inc. (HOOD). But which of these two stocks is more attractive to value investors?
NMR vs. HOOD: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
1 month ago
Are Investors Undervaluing Nomura (NMR) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Nomura (NMR) Right Now?
Positive
Seeking Alpha
1 month ago
Nomura: IB Could Recover In Ebullient Q1, Macquarie Integration Costs Will Pass
Nomura trades at a notable discount (11x PE) versus global peers, despite solid performances and temporarily depressed income. Temporary acquisition-related costs from the Macquarie deal will pressure profits through the next year, but underlying asset management inflows and alternative AUM growth remain robust. Wholesale and IB segments benefit from Japanese market dynamics, including PBR-related reform from the TSE for the Japan-facing IB businesses.
Nomura: IB Could Recover In Ebullient Q1, Macquarie Integration Costs Will Pass